Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug delivery to lymphatic tissue

M Papisov1, R Weissleder

  • 1MR Pharmaceutical Program, NMR Center, Department of Radiology, Massachusetts General Hospital, Charlestown, USA.

Critical Reviews in Therapeutic Drug Carrier Systems
|January 1, 1996
PubMed
Summary

Developing intravenous drug carriers that accumulate in lymph nodes is crucial for efficient disease diagnosis and therapy. This approach aims to overcome challenges associated with variable lymphatic drainage for targeted drug delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models.

Nature biotechnology·2026
Same author

Fluorescent PSMA-Targeted Radiotheranostic Compounds for Multiscale Imaging.

Bioconjugate chemistry·2025
Same author

Localized <i>in vivo</i> prodrug activation using radionuclides.

bioRxiv : the preprint server for biology·2024
Same author

Real-time high dynamic range laser scanning microscopy.

Nature communications·2016
Same author

Magnetic sensing technology for molecular analyses.

Lab on a chip·2014
Same author

In vivo imaging of specific drug-target binding at subcellular resolution.

Nature communications·2014

Area of Science:

  • Pharmacology
  • Biomedical Engineering
  • Drug Delivery Systems

Background:

  • Lymph node targeting is essential for effective disease diagnosis and therapy.
  • Macromolecular carriers administered locally accumulate in draining lymph nodes.
  • Variability in lymphatic networks necessitates systemic delivery strategies.

Purpose of the Study:

  • To review advances in intravenous drug carriers for lymph node targeting.
  • To highlight the importance of lymphotropic drug design for systemic administration.
  • To briefly discuss agents used for local lymph node delivery.

Main Methods:

  • Literature review of recent developments in intravenous lymphotropic drug carriers.
  • Analysis of strategies for enhancing drug retention in lymph nodes.

Related Experiment Videos

  • Summary of current approaches for local lymph node drug delivery.

    • Main Results:

    • Intralymphatic and interstitial administration show efficient lymph node accumulation.
    • Systemic administration of lymphotropic carriers is a key focus due to lymphatic variability.
    • Advances in intravenous carriers offer a promising alternative for targeted lymph node delivery.

    Conclusions:

    • Systemic delivery of lymphotropic drug carriers is preferred for overcoming lymphatic network variability.
    • Further development of intravenous carriers is critical for efficient lymph node-targeted therapies.
    • Targeted drug delivery to lymph nodes holds significant potential for disease management.